03326nam 2200661Ia 450 991101944750332120200520144314.09786611319724978128131972212813197249780470690246047069024097804707799580470779950(CKB)1000000000554328(EBL)351649(OCoLC)437218862(SSID)ssj0000312697(PQKBManifestationID)11239127(PQKBTitleCode)TC0000312697(PQKBWorkID)10332854(PQKB)10958892(MiAaPQ)EBC351649(Perlego)2788288(EXLCZ)99100000000055432820010615d2002 uy 0engur|n|---|||||txtccrVeterinary laboratory medicine clinical biochemistry and haematology /Morag G. Kerr2nd ed.Malden, MA Blackwell Science20021 online resource (386 p.)Description based upon print version of record.9780632040230 0632040238 Includes bibliographical references and index.Contents; Introduction; Part I: Haematology; 1 The Red Blood Cells (Erythrocytes); 2 The Platelets (Thrombocytes) and the Coagulation Factors; 3 The White Blood Cells (Leucocytes); Part II: Clinical Biochemistry; Introduction to Clinical Biochemistry; 4 The Plasma Proteins; 5 The Electrolytes; 6 The Minerals; 7 The Nitrogenous Substances; 8 Carbohydrate Metabolism; 9 Bilirubin and Fat Metabolism; 10 Clinical Enzymology - Plasma Enzymes in Diagnosis; I I Diagnostic Endocrinology; 12 Non-blood Body Fluids; 13 Feline Virus Testing; Part III: Systematic Investigation14 Investigation on an Individual Organ Basis15 Diagnostic Profiling and Pattern Recognition; Part IV: Practical Laboratory Medicine; 16 Sample Collection and Use of External Laboratories; 17 Side-room Testing in the Veterinary Practice; 18 The 'Practice Laboratory'; Suggested Further Reading; IndexVeterinary Laboratory Medicine covers all aspects of basic clinical biochemistry and haematology, and includes test-by-test interpretation of laboratory results. Information is provided on sampling techniques, the selection and use of an external laboratory, as well as near-patient testing and the practice laboratory. Also included are step-by-step instructions for most commonly used point-of-care tests, a guide to the evaluation of instruments for in-practice use, and a detailed explanation of the principles of impedance counting and photometric analysis. The book will be ideal for praVeterinary clinical pathologyVeterinary clinical biochemistryVeterinary hematologyVeterinary clinical pathology.Veterinary clinical biochemistry.Veterinary hematology.636.089636.08960756Kerr Morag G514376MiAaPQMiAaPQMiAaPQBOOK9911019447503321Veterinary laboratory medicine852328UNINA03693nam 2200625 a 450 991096569840332120251017110117.00-309-22217-61-280-38019-597866135581070-309-22215-X(CKB)2550000000103062(EBL)3378968(SSID)ssj0000649765(PQKBManifestationID)11404390(PQKBTitleCode)TC0000649765(PQKBWorkID)10610233(PQKB)10283136(MiAaPQ)EBC3378968(Au-PeEL)EBL3378968(CaPaEBR)ebr10557785(CaONFJC)MIL355810(OCoLC)923288168(DNLM)1585914(EXLCZ)99255000000010306220120519d2012 uy 0engurcn|||||||||txtccrStrengthening a workforce for innovative regulatory science in therapeutics development workshop summary /Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy1st ed.Washington, D.C. National Academies Press20121 online resource (119 p.)"Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy."0-309-22214-1 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 The Importance of Innovative Regulatory Science""; ""3 Defining a Discipline of Regulatory Science and Core Competencies for Its Workforce""; ""4 Education and Training of a Regulatory Science Workforce""; ""5 Career Paths Within Academia and Industry""; ""6 International Applications of Regulatory Science""; ""7 Collaborative Models and New Paradigms for Supporting Regulatory Science Research and Practice""; ""References""; ""Appendix A: Workshop Agenda""""Appendix B: Participant Biographies""The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop--Source other than Library of Congress.Drug developmentUnited StatesCongressesDrug development615.19Olsen Steve1807544Claiborne Anne B1805914Institute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation.Institute of Medicine (U.S.).Board on Health Sciences Policy.MiAaPQMiAaPQMiAaPQBOOK9910965698403321Strengthening a workforce for innovative regulatory science in therapeutics development4445937UNINA